OAT Prescriber's Guide Table of Contents

A print version of the Table of Contents is available in the PDF of the promotional flyer for the OAT Prescriber's Guide. 
 

Section I: Fundamental concepts and approaches in opioid agonist therapy

1   Opioid pharmacology and history
      Emily Kendell

2   Key concepts and theories of addiction
      Osnat C. Melamed, Peter Selby and Sara Ling

3   Opioid use disorder
      Dania Notta

4   Harm reduction
      Brandon Yau, Wendy Stevens, Emily Wagner, Josey Ross, Cheyenne Johnson and Christy Sutherland

5   Foundations of care and OAT provider roles
      Rosanra Yoon, Annabel Mead, Sara Ling and Maria Zhang
 

Section II: Treatment of opioid use disorder

 
6   OAT overview and impact on daily life
      Paxton Bach and Charl Els

7   Pharmacological treatment of opioid use disorder
      Seonaid Nolan, Christy Sutherland, Josey Ross, Evan Wood, M. Eugenia Socias, Wallace Yuen and Paxton Bach

8   Psychosocial interventions for opioid use disorder
      Rosanra Yoon and Vincent Lam
 

Section III: Opioid agonist therapy prescribing protocols and guidelines

 
9   Comprehensive assessment for OAT
      Dania Notta

10  OAT prescription standards and requirements
      Maria Zhang

11  Buprenorphine and methadone dosing
       Vincent Lam

12  Slow-release oral morphine
       Pamela Kaduri

13  Injectable opioid agonist therapy
       Scott Macdonald and Eugenia Oviedo-Joekes

14  Combination OAT and rotation
       Sarah Whynot and Nikki Bozinoff

15  Urine drug testing
       Cristiana Stefan

16  Take-home dosing
       Vincent Lam

17  Tapering OAT
       Vincent Lam

18  Termination of OAT
       Vincent Lam

19  Management of opioid overdose
       Michelle Klaiman and Alexander Caudarella
 

Section IV: Clinical issues in opioid agonist therapy

 
20  Chronic pain and opioid use disorder
       Robert L. Tanguay, Joel Bordman, Hance A. Clarke, Launette M. Rieb and Owen D. Williamson

21  Concurrent mental health disorders
       Ahmed N. Hassan

22  Concurrent substance use and OAT
       Francesca di Paola, Olivia Margie and Peter Selby

23  HIV and hepatitis C
       Neal Belluzzo, Kathryn Dorman, Maya Nader and James Owen

24  Pregnancy and OAT
       Alice Ordean

25  Neonatal abstinence syndrome
       Alice Ordean

26  OAT across the lifespan
       Sharon Cirone and Jonathan Bertram
 

Section V: Opioid agonist therapy in marginalized populations and specific settings

 
27  Social determinants of health and opioid use disorder
       Alyssa Kelly and S. Monty Ghosh

28  Poverty and opioid use disorder
       Larisa Eibisch

29  OAT with First Nations communities
       Jacqueline Nokusis, Lisa Richardson and Renee Linklater

30  Women and opioid use disorder
       Annabel Mead

31  OAT in institutional settings
       Robert McMaster, Michelle Klaiman and Alexander Caudarella

32  OAT in rural and remote settings
       Melissa Holowaty and Peter Selby

Canadian Opioid Use Disorder Guideline

Canada is in the midst of an opioid crisis, making it important to disseminate standardized approaches and evidence-based recommendations for managing opioid use disorder. Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder is a national clinical guideline that harmonizes existing guidelines, evidence-based practices and expert opinions into one document, with the aim of providing consistent and high-quality care to people with opioid use disorder.